Sambhara; Suryaprakash

Patent Applications and Registrations

Patent applications and USPTO patent grants for Sambhara; Suryaprakash.The latest application filed is for "method and composition against virus infections with activated innate lymphoid cells (ilcs)".

Company Profile

0.6.7

Sambhara; Suryaprakash - Atlanta GA
Sambhara; Suryaprakash - Markham CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method And Composition Against Virus Infections With Activated Innate Lymphoid Cells (ilcs) App 20220062357 - Suresh; Mittal ; et al.	2022-03-03
Vaccine against pandemic strains of influenza viruses Grant 8,163,545 - Sambhara , et al. April 24, 2	2012-04-24
Viral Therapy and Prophylaxis Using Nanotechnology Delivery Techniques App 20120009130 - Chakravarthy; Krishnan ; et al.	2012-01-12
Vaccine Against Pandemic Strains Of Influenza Viruses App 20100158939 - Sambhara; Suryaprakash ; et al.	2010-06-24
Enhancing Disease Resistance Against Rna Viral Infections With Intracytoplasmic Pathogen Sensors App 20100099745 - Sambhara; Suryaprakash ; et al.	2010-04-22
Multivalent immunogenic composition containing RSV subunit compostion and influenza virus preparation App 20080248057 - Cates; George A. ; et al.	2008-10-09
Vaccine Against Pandemic Strains Of Influenza Viruses App 20080187557 - Sambhara; Suryaprakash ; et al.	2008-08-07
Multivalent immunogenic composition containing RSV subunit composition and influenza virus preparation Grant 7,169,395 - Cates , et al. January 30, 2	2007-01-30
Multivalent immunogenic composition containing RSV subunit composition and influenza virus preparation App 20060159700 - Cates; George A. ; et al.	2006-07-20
Nucleic acid respiratory syncytial virus vaccines Grant 6,677,127 - Li , et al. January 13, 2	2004-01-13
Use of poxviruses as enhancer of specific immunity Grant 6,641,816 - Chevalier , et al. November 4, 2	2003-11-04
Nucleic acid respiratory syncytial virus vaccines Grant 6,083,925 - Li , et al. July 4, 2	2000-07-04
Nucleic acid respiratory syncytial virus vaccines Grant 5,843,913 - Li , et al. December 1, 1	1998-12-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.